Tysabri (tie-SAB-ree), the latest investigational treatment for multiple sclerosis (MS)
There's a lot of excitement about Tysabri (tie-SAB-ree), the latest investigational treatment for multiple sclerosis (MS).
Tysabri (natalizumab) is a monoclonal antibody. It blocks immune cells from entering the CNS and attacking nerves.
It seems to be more effective than the other MS drugs.
Practical advice for a better career, with unlimited access to CE
Pharmacy Technician's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 120+ CE courses, including the popular CE-in-the-Letter
- Helpful, in-depth Technician Tutorials
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote